Key takeaway: Fortis Healthcare Limited reported a consolidated revenue of INR 2,545 crores for Q1 FY27, reflecting a growth of 17.5% compared to the same quarter last year. The hospital business revenue increased by 19% to INR 2,187 crores, while the diagnostic business revenue grew by 10.2% to INR 407 crores. The operating EBITDA pre-ESOP expenses rose by 15.8% to INR 568 crores, with a margin of 22.3%. The company noted a steady hospital occupancy rate of 69% and an increase in occupied beds by 17%. Management highlighted the successful integration of recent acquisitions and ongoing expansion plans, including a new 300-bedded hospital in Cuttack. The diagnostics segment also showed growth, with a focus on enhancing operational efficiencies and expanding customer touchpoints. Management expressed confidence in sustaining growth momentum across both hospital and diagnostic businesses.

Key takeaway: Fortis Healthcare Limited's investor presentation for Q1 FY27 reported consolidated revenue of INR 2,545 crores, reflecting a 17.5% increase from the previous year. The hospital business generated revenues of INR 2,187 crores, up 19%, while the diagnostics segment reported gross revenues of INR 407 crores, a 10.2% growth. Operating EBITDA for the hospital business was INR 471 crores, with a margin of 21.5%, and the diagnostics business achieved an operating EBITDA margin of 23.9%. The presentation highlighted a slight decrease in occupancy rates to 68.7% and an increase in average revenue per occupied bed (ARPOB) to INR 2.71 crores. The company also noted a net debt of INR 2,233 crores, with a net debt to EBITDA ratio of 1.01x. Management emphasized growth in focus specialties and digital revenue channels, contributing significantly to overall performance.

Key takeaway: Fortis Healthcare Limited held its Q4 FY26 earnings conference call on May 25, 2026, where management reported a consolidated revenue of INR9,128 crores for the financial year, reflecting a 17.3% growth from FY25. The hospital business revenue grew by 19.1% to INR7,773 crores, while the diagnostic business reported a revenue of INR1,355 crores, an 8% increase. The operating EBITDA margin improved to 22.8% from 20.4% in the previous year. For Q4 FY26, consolidated revenue was INR2,365 crores, up 17.8% year-on-year, with a profit after tax increase of 44.2% to INR271 crores. Management highlighted a steady performance across both segments and announced a dividend of INR1 per share for the fourth consecutive year. The company also discussed its expansion plans, including the addition of approximately 800 beds and investments in medical infrastructure. The call concluded with a Q&A session addressing various operational queries.

Key takeaway: Fortis Healthcare Limited announced its financial results for Q4 FY26 and FY26, reporting consolidated revenues of INR 2,365 Cr for Q4 FY26, a 17.8% increase year-over-year, and INR 9,128 Cr for FY26, up 17.3% from FY25. Operating EBITDA for Q4 FY26 rose 22.2% to INR 531 Cr, with margins improving to 22.5%. Profit After Tax (PAT) for Q4 FY26 was INR 271 Cr, reflecting a 44.2% increase, while FY26 PAT reached INR 1,064 Cr, up 31.5%. The hospital business saw a revenue growth of 19.0% in Q4 FY26, driven by increased occupancy and key procedure volumes. The diagnostics segment also reported growth, with revenues of INR 387 Cr in Q4 FY26, an 11.1% increase. Management highlighted ongoing investments in medical equipment and network expansion, including acquisitions of hospitals and new facilities.

Key takeaway: Fortis Healthcare Limited reported its Q3 FY '26 earnings during the conference call held on February 16, 2026. Management highlighted a strong performance with consolidated revenues of INR 2,265 crores, reflecting a 17.5% increase year-on-year. The hospital segment saw a revenue growth of 19.4%, while the diagnostics business grew by 7.3%. Operating EBITDA rose by 34.8% to INR 505 crores, resulting in a margin of 22.3%. However, reported profit after tax (PAT) decreased to INR 197 crores, primarily due to a one-off expense related to new labor codes. Management noted the successful acquisition of People Tree Hospital and the launch of a specialized mental health facility, Adayu. The company added approximately 750 operational beds during the year and reported steady hospital occupancy rates. The diagnostics segment also showed improvement, with gross revenue increasing by 8.3%. Overall, management expressed confidence in maintaining growth momentum and expanding their market presence.

Key takeaway: Fortis Healthcare Limited reported its financial results for Q3 FY26, highlighting consolidated revenues of INR 2,265 crore, a 17.5% increase year-over-year. Operating EBITDA rose by 34.8% to INR 505 crore, with a margin of 22.3%, compared to 19.4% in Q3 FY25. Profit Before Tax (before exceptional items) was INR 312 crore, up 21.9% YoY. The hospital business generated revenues of INR 1,938 crore, reflecting a 19.4% increase, while operating EBITDA for this segment increased by 28.9%. The company also noted a net debt of INR 2,547 crore as of December 31, 2025, with a Net Debt to EBITDA ratio of 1.24x. Management mentioned the acquisition of the People Tree Hospital in Bengaluru and the launch of a specialized mental health facility, 'Adayu', as key developments. Overall, the results indicated strong growth across both hospital and diagnostics segments.